Latin Manharlal Chat
BSE Prices delayed by 5 minutes...
     Prices as on Sep 17, 2021     
  ABB India 1842.2 [ -3.58% ]
  ACC 2394.35 [ -1.42% ]
  Ambuja Cements Ltd. 420 [ -2.39% ]
  Axis Bank Ltd. 807.8 [ 0.65% ]
  Bank of Baroda 82.3 [ -4.25% ]
  Bharti Airtel 728.15 [ 1.39% ]
  Bharat Heavy Ele 56.55 [ -2.84% ]
  Bharat Petroleum 436.05 [ -0.67% ]
  Britannia Ind. 4053.9 [ -0.44% ]
  Cipla 954.15 [ 0.02% ]
  Coal India 156.7 [ -3.39% ]
  Colgate Palm. 1731.75 [ 0.90% ]
  Dabur India 653.95 [ 2.12% ]
  DLF Ltd. 334.6 [ -2.22% ]
  Grasim Inds. 1567.15 [ -0.76% ]
  HDFC 2825.3 [ 0.45% ]
  HDFC Bank 1583.3 [ 1.51% ]
  Hero MotoCorp 2931.5 [ 0.37% ]
  Hindalco Indus. 473 [ -2.05% ]
  ICICI Bank 720 [ -0.96% ]
  IDFC L 56.35 [ -2.51% ]
  Indian Hotels Co 149.05 [ -3.93% ]
  IndusInd Bank 1130.05 [ -0.11% ]
  Infosys 1691.3 [ -0.65% ]
  ITC Ltd. 231.1 [ 0.15% ]
  Jindal St & Pwr 386.6 [ -2.14% ]
  L&T 1715.5 [ -0.31% ]
  Lupin Ltd. 950.7 [ -1.76% ]
  Mahi. & Mahi 753.9 [ -0.38% ]
  MTNL 18.65 [ -4.85% ]
  Nestle India 20179.45 [ 0.68% ]
  NIIT Ltd. 321.65 [ -0.91% ]
  NMDC Ltd. 147.4 [ -3.12% ]
  NTPC 123.65 [ -0.28% ]
  ONGC 127.65 [ -0.82% ]
  Punj. NationlBak 39.7 [ -5.02% ]
  Power Grid Corpo 178.75 [ -0.36% ]
  Reliance Inds. 2390.4 [ -1.55% ]
  SBI 454.05 [ -2.07% ]
  Vedanta 301.75 [ -2.38% ]
  Shipping Corpn. 112.05 [ -2.18% ]
  Sun Pharma. 770.25 [ -1.36% ]
  Tata Chemicals 844.5 [ -2.39% ]
  Tata Motors Ltd. 308.5 [ -1.01% ]
  Tata Steel 1385.3 [ -3.57% ]
  Tata Power Co. 137.9 [ -1.68% ]
  Tech Mahindra 1452.35 [ 0.32% ]
  UltraTech Cement 7709.4 [ -0.79% ]
  United Spirits 741.45 [ -0.15% ]
  Wipro Ltd 664.85 [ -0.43% ]

News Details

Lupin to acquire Australia-based Southern Cross Pharma

Back
30/07/2021 11:57
Drug major Lupin on Friday said it will acquire Australia-based Southern Cross Pharma Pty Ltd (SCP). Incorporated in Melbourne, Australia, SCP is engaged in developing, registering, and distributing generic products.

Generic Health, the Australia based wholly-owned subsidiary of Lupin, has entered into a definitive agreement under which Lupin will acquire 100 per cent of the shares of Southern Cross Pharma Pty Ltd (SCP), Lupin said in a regulatory filing.

The company, however, did not disclose financial details of the transaction.

Lupin said as a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over AUD 30 million (approximately USD 22 million).

This will significantly increase Lupin"s value proposition and market share in the Australian market, the company said.

Nilesh Gupta, Managing Director Lupin said this is an important acquisition for the Australian entity and is aligned with Lupin"s strategy to expand and deepen its presence in select markets of focus.

"The Southern Cross Pharma portfolio builds on our existing portfolio of prescription generics, over the counter and specialty range of products. This investment significantly increases our scale in Australia and reinforces our commitment to patients in Australia," he said.

Ashutosh Damle, CEO, Generic Health said the company will benefit from SCP"s portfolio of over 60 difficult-to-develop generic pharmaceutical products.